CRLF2 and acute lymphoblastic leukemia: A bone marrow biopsy confirmed the relapse of Philadelphia-like B-ALL with complex molecular cytogenetics: CRLF2 rearrangement, CRLF2 exon 5 deletion, JAK2 gain, 9q34 abnormality, and mutations in ETV6, KRAS, and NRAS.